AMGN and MRK Related Headlines
Go Back- Barclays launches U.S. biopharma coverage with four preferred picks
- This U.S. biotech stock is Bernstein's Top Pick for 2026
- 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts
- Trump to announce prescription drug price agreements
- White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'
- Trump says we’ll be reducing prices (of drugs) by a 100% and in some cases more
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
